Analyzing Stock On Your Own: Akebia Therapeutics Inc (NASDAQ: AKBA)
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 2.04M shares in volume on a normal day but saw 1630554 shares change hands in the recent trading day. The company now has a market cap of 429.86M USD. Its current market price is $1.95, marking an increase of 1.04% compared to the previous close of $1.93. The 52 […]
Akebia Therapeutics Inc (NASDAQ: AKBA) Recovers 120.00% From 52-Week Low, Is AKBA Still A High-Risk, High-Reward Play?
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 1.95M but it saw 2680956 shares traded in last market. With a market cap of 384.00M USD, the company’s current market price of $1.76 came falling about -5.88 while comparing to the previous closing price of $1.87. In past 52 weeks, the stock […]
Do Investors Have Much Faith In Akebia Therapeutics Inc (NASDAQ: AKBA)
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 1.93M shares in volume on a normal day but saw 1748808 shares change hands in the recent trading day. The company now has a market cap of 410.29M USD. Its current market price is $1.85, marking an increase of 1.65% compared to the previous close of $1.82. The 52 […]
Akebia Therapeutics Inc (NASDAQ: AKBA) Recovers 140.00% From 52-Week Low, Is AKBA Still A High-Risk, High-Reward Play?
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 1.88M but it saw 3123274 shares traded in last market. With a market cap of 418.91M USD, the company’s current market price of $1.92 came falling about -3.03 while comparing to the previous closing price of $1.98. In past 52 weeks, the stock […]
Estimating Price Trends For Akebia Therapeutics Inc (NASDAQ: AKBA)
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 1.86M shares in volume on a normal day but saw 1542473 shares change hands in the recent trading day. The company now has a market cap of 453.91M USD. Its current market price is $2.05, marking an increase of 1.49% compared to the previous close of $2.02. The 52 […]
Akebia Therapeutics Inc (AKBA) Down -18.15% From Its 52-Week High, But Growth Potential Is Changing Over Time
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 1.88M but it saw 1618342 shares traded in last market. With a market cap of 442.91M USD, the company’s current market price of $2.03 came falling about -0.49 while comparing to the previous closing price of $2.04. In past 52 weeks, the stock […]
Akebia Therapeutics Inc (NASDAQ: AKBA) 52-Week High Located At $2.48, Forget The Dips, Just Ride The Rips
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 1.85M shares in volume on a normal day but saw 2135763 shares change hands in the recent trading day. The company now has a market cap of 449.45M USD. Its current market price is $2.06, marking no change compared to the previous close of $2.06. The 52 week high […]
Akebia Therapeutics Inc (NASDAQ: AKBA) 52-Week High Located At $2.48, Forget The Dips, Just Ride The Rips
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 1.80M shares in volume on a normal day but saw 2007342 shares change hands in the recent trading day. The company now has a market cap of 423.70M USD. Its current market price is $1.88, marking an increase of 3.30% compared to the previous close of $1.82. The 52 […]
How Worried Should Investors Be About Akebia Therapeutics Inc (AKBA)
Akebia Therapeutics Inc (NASDAQ:AKBA) does about 1.82M shares in volume on a normal day but saw 1159404 shares change hands in the recent trading day. The company now has a market cap of 397.09M USD. Its current market price is $1.82, marking an increase of 1.11% compared to the previous close of $1.80. The 52 […]
Should Investors Trust The Upside Potential In Akebia Therapeutics Inc (AKBA)?
Akebia Therapeutics Inc (NASDAQ:AKBA) currently has a daily average trading volume of 1.82M but it saw 1590662 shares traded in last market. With a market cap of 405.82M USD, the company’s current market price of $1.86 came falling about -3.12 while comparing to the previous closing price of $1.92. In past 52 weeks, the stock […]
